Clinical Trial Update: A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant study evaluating pemetrexed with folic acid given before surgery for rectal cancer; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• folic acid (folic acid)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Rectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2009-07-21